Abstract
Purpose
To retrospectively assess the feasibility, safety, and efficacy of artificial carbon dioxide (CO2) pneumothorax for computed tomography (CT) fluoroscopy-guided percutaneous radiofrequency (RF) ablation of hepatocellular carcinoma (HCC).
Materials and methods
This study included 26 sessions of 24 patients in whom the creation of artificial CO2 pneumothorax was attempted to avoid the transpulmonary route during CT fluoroscopy-guided percutaneous RF ablation of HCC between April 2011 and December 2017. In these 26 sessions, 29 HCCs (mean tumor diameter: 12 mm, range: 6–22 mm) were treated.
Results
Adequate lung displacement after induction of artificial CO2 pneumothorax was achieved in 23 of the 26 sessions (88.5%). In the remaining three sessions, transpulmonary RF ablation, transthoracic extrapulmonary RF ablation after switching to an artificial pleural effusion procedure, or RF ablation with electrode insertion in the caudal-cranial oblique direction was performed. No major complications were found. Among the 29 treated tumors, one (3.4%) showed local progression, and the other 28 (96.6%) were completely ablated at the last follow-up (mean follow-up period: 39.3 months, range: 7–78 months).
Conclusion
Artificial CO2 pneumothorax for CT fluoroscopy-guided percutaneous RF ablation appeared to be a feasible, safe, and useful therapeutic option for HCC.
Similar content being viewed by others
References
Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging. 2009;34:371–80.
Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, et al. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol. 2013;18:46–53.
Shibata T, Shibata T, Maetani Y, Kubo T, Itoh K, Togashi K, et al. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol. 2004;15:1323–7.
Park BJ, Byun JH, Jin YH, Won HJ, Shin YM, Kim KW, et al. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol. 2009;20:490–9.
Yamakado K, Nakatsuka A, Takaki H, Sakurai H, Isaji S, Yamamoto N, et al. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation. AJR Am J Roentgenol. 2010;194:530–5.
Toyoda M, Kakizaki S, Horiuchi K, Katakai K, Sohara N, Sato K, et al. Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol. 2006;12:608–11.
Valle LG, Rochal RD, Rahal A Jr, Garcia RG. Percutaneous CT-guided ablation in the hepatic dome: artificially induced pneumothorax for safe transpleural access. J Clin Imaging Sci. 2015;5:63.
Okuma T, Matsuoka T, Tutumi S, Nakmura K, Inoue Y. Air embolism during needle placement for CT-guided radiofrequency ablation of an unresectable metastatic lung lesion. J Vasc Interv Radiol. 2007;18:1592–4.
Favelier S, Guiu S, Cherblanc V, Cercueil JP, Krausé D, Guiu B. Transthoracic adrenal biopsy procedure using artificial carbon dioxide pneumothorax as outpatient procedure. Cardiovasc Intervent Radiol. 2013;36:1184–7.
Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199-202.
Hermida M, Cassinotto C, Piron L, Assenat E, Pageaux GP, Escal L, et al. Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy. Int J Hyperthermia. 2018;35:90–6.
Gou XH, Yang W, Zhang YL, Li Y, Wu X. A case of massive cerebral arterial air embolism induced by artificial pneumothorax and its analysis. Med Princ Pract. 2019;28:297–300.
Caso R, Kelly CH, Marshall MB. Single lumen endotracheal intubation with carbon dioxide insufflation for lung isolation in thoracic surgery. Surg Endosc. 2019;33:3287–90.
Han KN, Kim HK, Lee HJ, Lee DK, Kim H, Lim SH, et al. Single-port thoracoscopic surgery for pneumothorax under two-lung ventilation with carbon dioxide insufflation. J Thorac Dis. 2016;8:1080–6.
Sancheti MS, Dewan BP, Pickens A, Fernandez FG, Miller DL, Force SD. Thoracoscopy without lung isolation utilizing single lumen endotracheal tube intubation and carbon dioxide insufflation. Ann Thorac Surg. 2013;96:439–44.
Buy X, Tok CH, Szwarc D, Bierry G, Gangi A. Thermal protection during percutaneous thermal ablation procedures: interest of carbon dioxide dissection and temperature monitoring. Cardiovasc Intervent Radiol. 2009;32:529–34.
De Baère T, Dromain C, Lapeyre M, Briggs P, Duret JS, Hakime A, et al. Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology. 2005;236:666–70.
Fujiwara H, Arai Y, Ishii H, Kanazawa S. Computed tomography-guided radiofrequency ablation for sub-diaphragm hepatocellular carcinoma: safety and efficacy of inducing an artificial pneumothorax. Acta Med Okayama. 2016;70:189–95.
Scalzetti EM. Protective pneumothorax for needle biopsy of mediastinum and pulmonary hilum. J Thorac Imaging. 2005;20:214–9.
Kamei S, Matsuda J, Hagihara M, Kitagawa A, Izumi Y, Katsuda E, et al. Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma. Jpn J Radiol. 2012;30:533–9.
Kim YK, Kim CS, Lee JM, Chung GH, Chon SB. Efficacy and safety or radiofrequency ablation of hepatocellular carcinoma in the hepatic dome with the CT-guided extrathoracic transhepatic approach. Eur J Radiol. 2006;60:100–7.
Koda M, Ueki M, Maeda Y, Mimura K, Okamoto K, Matsunaga Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol. 2004;183:583–8.
Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Inoue T, et al. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol. 2003;38:1066–70.
Solomon SB, Thornton RH, Dupuy DE, Downey RJ. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol. 2008;19:610–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Our institution’s Ethics Committee approved this retrospective study. The requirement for written informed consent for this study was waived because of its retrospective nature.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shibamoto, K., Mimura, H., Fukuhara, Y. et al. Feasibility, safety, and efficacy of artificial carbon dioxide pneumothorax for computed tomography fluoroscopy-guided percutaneous radiofrequency ablation of hepatocellular carcinoma. Jpn J Radiol 39, 1119–1126 (2021). https://doi.org/10.1007/s11604-021-01148-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-021-01148-y